The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation
NCT05913596
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Antibody-mediated Rejection
Kidney Tranplant
Interventions
DRUG:
Daratumumab
Sponsor
First Affiliated Hospital of Zhejiang University